Mobile health company Medisafe revealed on Tuesday that it will deliver an innovative new section within its medication management platform to support Pradaxa patients in the US in partnership with Boehringer Ingelheim Pharmaceuticals Inc, a global, research-driven pharmaceutical company.

Medisafe will offer access within the overall Medisafe app to a section with educational materials specific to Pradaxa including health literacy videos, relevant health tips and a Pradaxa Savings Card to certain individuals who are taking Pradaxa (dabigatran etexilate mesylate), an anticoagulant medication.

More than just a pill organizer and reminder, Medisafe makes it easy to adhere to the most complicated medication schedules, enables care collaboration between a patient, their loved ones and providers, and delivers educational content and services tailored to specific conditions and situations.

In conjunction, the Medisafe app has been ranked number one of 272 medication adherence apps in an independent research study published in the leading open-access journal JMIR. Over 160K people have reviewed and rated the app 4.5 out of five stars in the app stores.